Pillar Biosciences
PrivateLast Round
Strategic
May 27, 2025
Total Funding Raised
$102.2M
Company Overview
Pillar Biosciences operates in Healthcare & Life Sciences and is based in Natick, Massachusetts. Its latest recorded funding round was a Strategic round in May 2025.
Pillar Biosciences is a biotechnology company that develops and manufactures targeted next-generation sequencing (NGS) panels and bioinformatics software for clinical cancer diagnostics.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Biotech Equipment, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Pillar Biosciences Comparables
Compare Pillar Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Paragon Genomics | 83% | |
| EntroGen, Inc. | 80% | |
| Labcorp | 76% |
For institutional investors. Book with your work email.
Pillar Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Strategic | May 27, 2025 | ||||
| Series D | May 1, 2021 | ||||
| Series C | May 12, 2020 | ||||
| Series B | Nov 1, 2018 | ||||
| Series A | May 11, 2016 |
For institutional investors. Book with your work email.
Pillar Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| HB Ventures | Series C |
| Soleus Capital | Strategic |
| ORI Capital | Series A, Series C |
| Infinity Group | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 21, 2026
Monthly visitors grew 46% MoM, reaching 4.4K.
- Apr 2, 2026
Partnered with CellCarta for global tumor profiling.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- launchesOct 22, 2026
Pillar Biosciences, Inc. launches the research-use-only, kitted NGS panel for acute myeloid leukemia minimal residual disease detection, combining ultrasensitive NPM1 and FLT3-ITD detection in a single-tube, DNA-based workflow for in-house laboratory use in Massachusetts on Oct 22nd '26.
- launchesOct 22, 2026
Pillar Biosciences, Inc. launches the research-use-only MRDTect(TM) NPM1 and FLT3 ITD Panel in Massachusetts on Oct 22nd '26 to support in-house, ultrasensitive NGS-based measurable residual disease detection in acute myeloid leukemia.
- hiresSep 3, 2026
Pillar Biosciences, Inc. appoints Todd Christian, Illumina’s Senior Vice President of Services, Arrays and Genomics Access, to its Board of Directors in Massachusetts on Sep 3rd '26 following its latest strategic financing.
- hiresSep 3, 2026
Pillar Biosciences, Inc. appoints Todd Christian to its Board of Directors alongside Yann Echelard, Ph.D., following its Jul 31st '26 strategic financing, in Massachusetts on Sep 3rd '26.
- hiresSep 3, 2026
In Massachusetts on Sep 3rd '26, Pillar Biosciences, Inc. appoints Yann Echelard, Ph.D., a Partner at ORI Capital, to its Board of Directors alongside Todd Christian following strategic financing.
For institutional investors. Book with your work email.
Pillar Biosciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Pillar Biosciences's valuation, stock price, and market status.
Is Pillar Biosciences a public or private company?
Pillar Biosciences is a private company.
What is the current stock price of Pillar Biosciences?
Pillar Biosciences is a private company, so its shares have no public market price. Caplight tracks Pillar Biosciences's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Pillar Biosciences worth (valuation)?
Valuation information for Pillar Biosciences is not publicly available.
Can I buy Pillar Biosciences stock?
Pillar Biosciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Pillar Biosciences's last funding round?
Pillar Biosciences's most recent funding round was Strategic on May 27, 2025.
Who are the main investors in Pillar Biosciences?
Key investors in Pillar Biosciences include ORI Capital.
Will Pillar Biosciences IPO soon?
No public IPO plans have been announced for Pillar Biosciences.
How can I track Pillar Biosciences secondary market activity?
Caplight tracks bids, offers, and trades in Pillar Biosciences's shares on secondary markets.